Jamie C. DeWitt

Immunotoxicity of perfluorooctanoic acid and perfluorooctane sulfonate and the role of peroxisome proliferator-activated receptor alpha.

Developmental toxicity in white leghorn chickens following in ovo exposure to perfluorooctane sulfonate (PFOS).

Suppression of humoral immunity by perfluorooctanoic acid is independent of elevated serum corticosterone concentration in mice.

Breaking patterns of environmentally influenced disease for health risk reduction: immune perspectives.

Are developmentally exposed C57BL/6 mice insensitive to suppression of TDAR by PFOA?

Immunotoxicity of perfluorinated compounds: recent developments.

Current status of developmental immunotoxicity: early-life patterns and testing.

Perflurooctanoic acid induces developmental cardiotoxicity in chicken embryos and hatchlings.

Developmental immunotoxicity (DIT): assays for evaluating effects of exogenous agents on development of the immune system.

Does developmental exposure to perflurooctanoic acid (PFOA) induce immunopathologies commonly observed in neurodevelopmental disorders?

Perfluorooctanoic acid induced-developmental cardiotoxicity: are peroxisome proliferator activated receptor α (PPARα) and bone morphorgenic protein 2 (BMP2) pathways involved?

Environmental risk factors for autism.

Perfluorinated compounds: emerging POPs with potential immunotoxicity.

Suppression of antigen-specific antibody responses in mice exposed to perfluorooctanoic acid: Role of PPARα and T- and B-cell targeting.

Association of Perfluoroalkyl Substances, Bone Mineral Density, and Osteoporosis in the U.S. Population in NHANES 2009-2010.

Perfluorooctanoic acid-induced toxicity in primary cultures of chicken embryo cardiomyocytes.

Associating Changes in the Immune System with Clinical Diseases for Interpretation in Risk Assessment.

Health effects following subacute exposure to geogenic dusts from arsenic-rich sediment at the Nellis Dunes Recreation Area, Las Vegas, NV.

Demographic, Reproductive, and Dietary Determinants of Perfluorooctane Sulfonic (PFOS) and Perfluorooctanoic Acid (PFOA) Concentrations in Human Colostrum.

Evaluation of the immunomodulatory effects of 2,3,3,3-tetrafluoro-2-(heptafluoropropoxy)-propanoate in C57BL/6 mice.

A Never-Ending Story of Per- and Polyfluoroalkyl Substances (PFASs)?

A single dose of trichloroethylene given during development does not substantially alter markers of neuroinflammation in brains of adult mice.

Health effects following subacute exposure to geogenic dust collected from active drainage surfaces (Nellis Dunes Recreation Area, Las Vegas, NV).

Nevada desert dust with heavy metals suppresses IgM antibody production.

Developmental Immunotoxicity (DIT) Testing: Current Recommendations and the Future of DIT Testing.

Exposure to per-fluoroalkyl and polyfluoroalkyl substances leads to immunotoxicity: epidemiological and toxicological evidence.

Dysfunctional microglia:neuron interactions with significant female bias in a developmental gene x environment rodent model of Alzheimer's disease.

The concept of essential use for determining when uses of PFASs can be phased out.

Bioaccumulation of Novel Per- and Polyfluoroalkyl Substances in Mice Dosed with an Aqueous Film-Forming Foam.

Strategies for grouping per- and polyfluoroalkyl substances (PFAS) to protect human and environmental health.

Immunotoxicity of an Electrochemically Fluorinated Aqueous Film-Forming Foam.

Per- and Polyfluoroalkyl Substance Toxicity and Human Health Review: Current State of Knowledge and Strategies for Informing Future Research.

Are Fluoropolymers Really of Low Concern for Human and Environmental Health and Separate from Other PFAS?

An overview of the uses of per- and polyfluoroalkyl substances (PFAS).

The high persistence of PFAS is sufficient for their management as a chemical class.